Industry News - Tag: Johnson & Johnson

You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

J&J steps up Tylenol production for COVID-19
Premium

16 April 2020

Johnson & Johnson’s (J&J’s) OTC sales in the US increased by more than a third in the first quarter of 2020 amid the COVID-19 pandemic. Chairman and chief executive officer Alex Gorsky said the company had increased and refocused production of Tylenol (acetaminophen).

Read the full story

J&J plans to streamline Consumer portfolio
Premium

23 January 2020

Johnson & Johnson (J&J) has announced plans to “rationalise” the product portfolio of its Consumer division. The news came as the division reported worldwide sales up by 2.1% on an operational basis in the fourth quarter of 2019.

Read the full story